← All tickers

Is REPL Worth Buying in 2026?

Replimune Group, Inc.

STOCK BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Updated 2026-07-26

Here’s whether Replimune Group, Inc. (REPL) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+18.21% over 10 days); strong 1-year return of +212.9%; 3-month momentum positive (+300.8%). Currently 22.4% off its 52-week high. Score: +6/7.

Ready to act on this? 📈 Trade on Webull

REPL is in a confirmed uptrend, trading above both its 50-day ($9.04) and 200-day ($7.76) moving averages. An RSI of 31.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +212.9% compares to +16.5% for SPY (beat the market by 196.4%). The current 22.4% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $31,290 today
vs. S&P 500 (SPY) — same period beat market by 196.4%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($7.76)
✓Above 50-day MA ($9.04)
✓RSI(14) neutral zone (30–70) — currently 31.6
✓Positive return (+212.9%)
!Within 10% of period high (−22.4%)
Period Range $9.70
$1.50 $12.50
RSI (14) 31.6
0 · OversoldOverbought · 100

Key Metrics

Price$9.70
Period Return+212.9%
Period High$12.50
Period Low$1.50
Drawdown−22.4%
MA-50$9.04
MA-200$7.76
RSI (14)31.6
Avg Volume (30d)3.1M
vs. SPYbeat by 196.4%
Return Rank#41 of 999

Trade REPL

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers